Catalog
| Catelog# | Product | CAS# | Formula | Purity(%) | Inquiry |
| 2A-9008723 | R-(-)-5-[2(2-Amino-2-methyl)ethyl]-2-methoxybenzenesulfonamide | 112101-81-2 | C10H16N2O3S | 98% | Inquiry |
| 2A-9008724 | R-(Tetrahydrofuran-2-yl)methanamine | 7202-43-9 | C5H11ON | 98% | Inquiry |
| 2A-9008725 | R-alpha-Lipoic acid | 62-46-4 | C8H14O2S2 | 98% | Inquiry |
| 2A-9008726 | Ramosetron hydrochloride | 132907-72-3 | C17H17N3O.HCl | 98% | Inquiry |
| 2A-9008727 | Rifamycin | 6998-60-3 | C39H47NO14 | 98.00% | Inquiry |
| 2A-9008728 | Ropinirole hydrochloride | 91374-20-8 | C16H24N2O.HCl | 98% | Inquiry |
| 2A-9008729 | Rosiglitazone maleate | 155141-29-0 | C18H19N3O3S.C4H4O4 | 98% | Inquiry |
| 2A-9008730 | Rotundinum | 2934-97-6 | C21H25NO4 | 90% | Inquiry |
| 2A-9008731 | Roxatidine acetate hydrochloride | 93793-83-0 | C19H28N2O4.HCl | 98% | Inquiry |
| 2A-9012248 | R(-)-Denopamine | 71771-90-9 | C18H23NO4 | 98% | Inquiry |
| 2A-9012249 | R-(+)-Ofloxacin | 2A-303333 | C18H20FN3O4 | 98% | Inquiry |
| 2A-9012250 | R(+)-Verapamil | 2A-303334 | C27H38N2O4 | 98% | Inquiry |
| 2A-9012251 | Rabeprazole Sodium | 117976-90-6 | C18H20N3NaO3S | 99% | Inquiry |
| 2A-9012252 | Racecadotril | 81110-73-8 | C21H23NO4S | 99% | Inquiry |
| 2A-9012253 | Ractopamine hydrochloride | 90274-24-1 | C18H23NO3•HCl | 98% | Inquiry |
| 2A-9012254 | Radix fissistigmae glaucesscentis | 2A-303338 | 98.00% | Inquiry | |
| 2A-9012255 | Radix Rehmanniae | 2A-303339 | 98.00% | Inquiry | |
| 2A-9012256 | RadixCodonopsisPilosulae | 2A-303340 | 98.00% | Inquiry | |
| 2A-9012257 | Rafoxanide | 22662-39-1 | C19H11Cl2I2NO3 | 98% | Inquiry |
| 2A-9012258 | Raloxifene | 84449-90-1 | C28H27NO4S | 98% | Inquiry |
| 2A-9012259 | Raloxifene hydrochloride | 82640-04-8 | C28H27NO4S.HCl | 98% | Inquiry |
| 2A-9012260 | Raltitrexed | 112887-68-0 | C21H22N4O6S | 98% | Inquiry |
| 2A-9012261 | Ramipril | 87333-19-5 | C23H32N2O5 | 98% | Inquiry |
| 2A-9012262 | Ramiprilat | 87269-97-4 | C21H28N2O5 | 98% | Inquiry |
| 2A-9012263 | Ramnodigin | 33156-28-4 | C29H44O6 | 98.00% | Inquiry |